Vaccines against pregnancy-associated malaria

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9540425
APP PUB NO 20130129767A1
SERIAL NO

13812197

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to specific regions of the N-terminal portion of the VAR2CSA protein and to the use of such specific regions in the prevention of pregnancy-associated malaria. The invention also provides immunogenic compositions and vaccines that are useful for preventing malaria in pregnant women.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
INSTITUT DE RECHERCHE POUR LE DEVELOPPEMENT (IRD)13002 MARSEILLE 2

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bigey, Pascal Paris, FR 12 79
Deloron, Philippe Paris, FR 2 7
Gnidéhou, Sedami Ursula Alix Carine Tavemy, FR 1 7
Ndam, Nicaise Tuikue Paris, FR 2 0
Quiviger, Mickaël Le Grand Quevilly, FR 1 7
Scherman, Daniel Paris, FR 50 543

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 10, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00